Investigating how drug abuse affects HIV-1 replication through RNA modifications
RNA post-transcriptional modifications as possible communication hubs between substances of abuse and HIV-1 replication processes
This study is looking at how cocaine use might affect the way HIV-1 copies itself in the body, focusing on specific changes in RNA that could help us find better treatments for people dealing with both HIV and drug abuse.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10347372 on NIH RePORTER |
What this research studies
This research explores the relationship between drug abuse, specifically cocaine, and the replication processes of HIV-1 at a molecular level. It focuses on understanding how RNA post-transcriptional modifications, particularly N6-methyladenosine (m6A), influence the interaction between drug effects and viral replication. By employing advanced mass spectrometry techniques, the study aims to identify various RNA modifications and their roles in mediating communications between drug influences and HIV-1 processes. This could lead to new insights into improving anti-retroviral treatments for individuals affected by both drug abuse and HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also have a history of drug abuse.
Not a fit: Patients who are not living with HIV or do not have a history of drug abuse may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for HIV patients who also struggle with substance abuse.
How similar studies have performed: While the specific approach of investigating RNA modifications in the context of drug abuse and HIV-1 is innovative, related research has shown that understanding molecular interactions can lead to significant advancements in treatment.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Fabris, Daniele — University of Connecticut Storrs
- Study coordinator: Fabris, Daniele
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.